Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Tandem Diabetes Care (TNDM) Net Margin (2016 - 2026)

Tandem Diabetes Care filings provide 13 years of Net Margin readings, the most recent being 0.18% for Q4 2025.

  • On a quarterly basis, Net Margin fell 45.0% to 0.18% in Q4 2025 year-over-year; TTM through Dec 2025 was 20.17%, a 996.0% decrease, with the full-year FY2025 number at 20.17%, down 996.0% from a year prior.
  • Net Margin hit 0.18% in Q4 2025 for Tandem Diabetes Care, up from 8.49% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 5.13% in Q4 2021 to a low of 73.13% in Q1 2023.
  • Median Net Margin over the past 5 years was 9.0% (2024), compared with a mean of 14.79%.
  • Biggest five-year swings in Net Margin: plummeted -6479bps in 2023 and later skyrocketed 5084bps in 2024.
  • Tandem Diabetes Care's Net Margin stood at 5.13% in 2021, then plummeted by -241bps to 7.21% in 2022, then plummeted by -111bps to 15.23% in 2023, then surged by 102bps to 0.27% in 2024, then tumbled by -164bps to 0.18% in 2025.
  • The last three reported values for Net Margin were 0.18% (Q4 2025), 8.49% (Q3 2025), and 21.77% (Q2 2025) per Business Quant data.